| |
|
Form Serial Number: |
DA20261008E00544
|
| 1.
Date of relevant event: |
06/10/2026
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02652 |
| 4.
Name of listed corporation: |
CF PharmTech, Inc. - H Shares |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
323,971,286 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
BOVET |
| (Other names) |
LI LI |
|
|
|
| 10.
Name of director (Chinese): |
李勵 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1113 | The number of shares in which you are interested has increased because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2103 | Interests held jointly with another person |
|
| 2103 | Interests held jointly with another person |
|
19,300 |
HKD |
6.9650 |
6.9216 |
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 60,697,233 | 18.74 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 60,716,533 | 18.74 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
| 2103 | Interests held jointly with another person |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| 正祥納國際有限公司 | Unit D, 16/F, One Capital Place, 18 Luard Road, Wan Chai, Hong Kong | LI LI BOVET | 100.00 | N | |
| 蘇州美中瑞投資管理企業（有限合夥） | 蘇州市漕湖街道錢涇路1 號漕湖大廈19 樓1941 房屋 | 正祥納國際有限公司 | 100.00 | Y | |
| 蘇州閩美投資管理企業（有限合夥） | 蘇州市漕湖街道錢涇路1 號漕湖大廈19 樓1941 房屋 | 蘇州美中瑞投資管理企業（有限合夥） | 37.70 | Y | |
| 蘇州遠辰企業管理中心（有限合夥） | 蘇州市漕湖街道錢涇路1 號漕湖大廈19 樓1941 房屋 | 蘇州美中瑞投資管理企業（有限合夥） | 38.71 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| 蘇州嶺頭投資管理企業（有限合夥） | Addresses of individuals are not displayed. | |
| 蘇州沃倫企業管理中心（有限合夥） | Addresses of individuals are not displayed. | |
| 嶺頭投資有限公司 | Addresses of individuals are not displayed. | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
Pursuant to the Acting-in-Concert Agreement, Dr. LIANG Bill Wenqing and Dr. LI LI BOVET are parties acting in concert. Accordingly, under the SFO, each of them is deemed to be interested in the Shares in which the other is interested. On October 6, 2026, Dr. LIANG purchased 19,300 H Shares through HK Pyramid. Under the SFO, Dr. LI LI BOVET is deemed to be interested in these H Shares. For details, please refer to the form disclosed by Dr. LIANG.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
08/10/2026
(dd/mm/yyyy)
|
| |